Tuberculosis biomarkers discovery: developments, needs, and challenges
- 1 April 2013
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 13 (4), 362-372
- https://doi.org/10.1016/s1473-3099(13)70034-3
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care testThe Lancet Infectious Diseases, 2013
- Rapid detection of Mycobacterium tuberculosis biomarkers in a sandwich immunoassay format using a waveguide-based optical biosensorTuberculosis, 2012
- Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2011
- T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosisTuberculosis, 2011
- Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis‐infected and culture filtrate protein‐treated macrophagesProteomics, 2010
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Antimicrobial activity of mucosal-associated invariant T cellsNature Immunology, 2010
- Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosisTuberculosis, 2009
- A New Recombinant Bacille Calmette‐Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis‐Specific Immunity in Human VolunteersThe Journal of Infectious Diseases, 2008
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001